Advertisement

Tumor Cell Mediated Degradation In Vitro of Antitumor Antibodies

  • Y. Keisari
  • I. P. Witz
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 23)

Abstract

An in vivo interaction between tumor cells and humoral immune components was strongly supported by the findings that malignant tumor cells of human and animal origin are coated in vivo with Ig molecules. In some tumor host systems it was possible to show that at least some of the tumor bound Ig molecules expressed antibody activity against the tumor cells [13].

Keywords

Ammonium Sulfate Lysosomal Enzyme Rabbit Antiserum Lower Molecular Weight Range Antitumor Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bosmann, H.B., Hall, T.C.: Enzyme activity in invasive tumors of human breast and colon. Proc. Nat. Acad. Sci. USA 71, 1833–1837 (1974)PubMedCrossRefGoogle Scholar
  2. 2.
    Cotropia, J. P., Gutterman, J.V., Hersh, E. M., Granatek, C.H., Mavligit, G.M.: Antigenic expression and cell surface properties of human leukemic blasts. Ann. N.Y. Acad. Sci. 276, 146–164 (1976)PubMedCrossRefGoogle Scholar
  3. 3.
    Dauphinee, M.J., Talal, N., Witz, I.P.: Generation of non-complement-fixing blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies. J. Immunol. 113, 948–953 (1974)PubMedGoogle Scholar
  4. 4.
    Haskill, J.S., Yamamura, Y., Radov, L.A.: Host responses within solid tumors: Non-thymus derived specific cytotoxic cells within a murine mammary adenocarcinoma. Int. J. Cancer 16, 798–809 (1975)PubMedCrossRefGoogle Scholar
  5. 5.
    Hellstrom, K.E., Hellstrom, I.: Lymphocyte mediated cytotoxicity and blocking serum activity to tumor antigens. Adv. Immunol. 18, 209–277 (1974)PubMedCrossRefGoogle Scholar
  6. 6.
    Keisari, Y., Witz, I. P.: Degradation of immunoglobulins by lysosomal enzymes of tumors. I. Demonstration of the phenomenon using mouse tumors. Immunochemistry 10, 565–570 (1973)PubMedCrossRefGoogle Scholar
  7. 7.
    Keisari, Y., Witz, I. P.: The specific blocking of humoral immune cytolysis mediated by antitumor antibodies degraded by lysosomal enzymes of tumor origin. Eur. J. Immunol. 5, 790 to 795 (1975)PubMedCrossRefGoogle Scholar
  8. 8.
    Marbrook, J.: Primary immune response in cultures of spleen cells. Lancet 1967 II, 1279 to 1281Google Scholar
  9. 9.
    Roblin, R., Chou, I.N., Black, P.H.: Proteolytic enzymes, cell-surface changes and viral transformation. Adv. Cancer Res. 22, 203–252 (1975)CrossRefGoogle Scholar
  10. 10.
    Shamberger, R.J., Hozumi, M., Morris, H.P.: Lysosomal and non-lysosomal enzyme activities of Morris hepatomas. Cancer Res. 31, 1632–1639 (1971)PubMedGoogle Scholar
  11. 11.
    Sobczak, R., De Vaux St. Cyr, Ch.H.: Study of the in vivo fixation of antibodies on tumor provoked in hamsters by injection of SV-40 transformed cells (TSV5Cl2). Int. J. Cancer 8, 47–52 (1971)PubMedCrossRefGoogle Scholar
  12. 12.
    Sylven, B.: Lysosomal enzyme activity in the interstitial fluid of solid mouse tumor transplants. Eur. J. Cancer 4,463–474 (1968)PubMedGoogle Scholar
  13. 13.
    Witz, I.P.: Tumor bound immunoglobulins. In situ expressions of humoral immunity. Adv. Cancer Res. 25, 95–148 (1977)PubMedCrossRefGoogle Scholar
  14. 14.
    Witz, I.P., Levy, H.J., Keisari, Y., Izsak, F.Ch.: Tumor bound immunoglobulins: Their possible role in circumventing antitumor immunity. In: The role of immunological factors in viral and oncogenic processes. Beers, R.S., Jr., Tilghman, R.C., Bassett, E.G. (eds.). pp. 289 to 300. Baltimore, Maryland: Johns Hopkins Univ. Press 1974Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • Y. Keisari
    • 1
  • I. P. Witz
    • 2
  1. 1.Laboratory of Immunobiology, National Cancer InstituteNational Institutes of HealthBethesdaUSA
  2. 2.Department of Microbiology, The George S. Wise Center for Life SciencesTel Aviv UniversityRamat Aviv, Tel AvivIsrael

Personalised recommendations